Phage Therapy in Germany-Update 2023.

Area of Science:

• Microbiology
• Infectious Diseases
• Biotechnology

Background:

• Antibiotic resistance is a growing global health crisis.
• Bacteriophage therapy offers a potential alternative to antibiotics.
• Germany is exploring phage therapy applications and research.

Purpose of the Study:

• To provide an overview of the current state of phage therapy in Germany (2023).
• To identify critical shortcomings and areas for development in applied phage therapy.
• To inform future strategies for advancing phage therapy research and clinical use.

Main Methods:

• Review of current phage production, phage banks, and susceptibility testing.
• Analysis of clinical applications and ongoing translational research.
• Assessment of the regulatory landscape and network structures in Germany.

Main Results:

• Limited clinical trials and a lack of appropriate regulation hinder widespread use.
• Shortage of phages for clinical application and limited exchange between phage banks.
• Increased phage research projects and networking, but insufficient production capacity and clinical guidelines.

Conclusions:

• Urgent need for expanded production, standardized quality, patient registries, and clear guidelines.
• Medical community requires better education on phage therapy.
• Phage therapy application should proceed cautiously, potentially following models like Belgium's, with regulatory coordination and increased translational research funding.